Katalyst Continues Worldwide Growth by Acquiring Geopost Energy
14.9.2022 16:03:00 EEST | Business Wire | Press release
Katalyst Data Management announced today that it will acquire the Rio de Janeiro-based oil and gas data product and service provider Geopost Energy. Geopost Energy provides instant online access to integrated data of all types, including seismic, interpretations, and well logs production data to its clients. In addition, Geopost offers continuously updated information and news on all aspects of Brazil’s offshore and onshore E&P activities. The acquisition represents an important expansion to the South American region for Katalyst, underpinning their increasing capabilities to support their customers in any region they operate. The Brazilian office will act as a hub for Katalyst in South America and add to Katalyst’s global footprint including data centers in Canada, the United States, the United Kingdom, Australia, and Malaysia.
The transaction is subject to customary closing conditions.
Global reach for end-to-end subsurface data management
“This acquisition marks another milestone in our journey to have a presence in major oil and gas data markets across the globe,” said Katalyst President and CEO, Steve Darnell. “We have long admired the technology and services that Geopost brings to the market. In addition to the growth of Geopost’s products into our existing regions, we are excited about our ability to incorporate their key technologies into iGlass and SeismicZone. We believe this will greatly enhance our already industry leading capabilities.”
“We are thrilled to become part of the Katalyst family," said Christiano Lopes, Geopost’s CEO. “The combination of Katalyst’s industry leading organization, global footprint, and expertise with the technology and services developed by Geopost will contribute to a broader solution generating new opportunities in multiple regions. It is a huge opportunity for us as we advance.”
About Katalyst
Katalyst Data Management provides a complete data management solution assisting oil and gas companies with the difficult challenge of managing the vast amount of subsurface data and information acquired for exploration and production. Katalyst’s end-to-end solution includes every step in the process, from data capture and verification, data storage and organization, to marketing seismic data online. Katalyst’s signature offerings include the web-based iGlass solution for subsurface data management and the ecommerce site SeismicZone for data marketing. To learn more about Katalyst, visit www.katalystdm.com.
About Geopost Energy
With their leading technology platform, Geopost provides instant access to data related to the E&P market (e.g., seismic data, interpretations, wells, production charts, bidding round history, E&P assets, and others). Everything is built into a fluid and easy-to-use platform. The environment combines customer’s private library with automatically updated information covering all aspects of Brazil's E&P Offshore and Onshore activities. Geopost is an essential tool for your technical and business team.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220829005050/en/
Contact information
Katalyst Data Management
Steve Darnell, President and CEO
Steve.Darnell@katalystdm.com
+1 281.529.3202
Geopost Energy
Christiano Lopes, CEO
Christiano.Lopes@geopostenergy.com
+55 21 3535 9698
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom